The US Food and Drug Administration (FDA) has changed its position on vaping and Covid-19, saying that there is no known evidence that vaping puts an individual at a higher risk of developing complications tied to the virus.
The agency previously stated that vapers were at an elevated risk of developing complications.
Previously, on March 31, Iowa’s attorney general, Tom Miller, joined a group of scientists and policy experts which included professors from Harvard, New York University, and the University of Michigan in sending a letter to FDA critiquing its previous stance on vaping and the coronavirus. The letter was in response to an earlier Bloomberg News story, titled "Vaping Could Compound Health Risks Tied to Virus, FDA Says."
The letter’s authors arugued that the article's headline did not make it clear that FDA was stating that vaping "could compound health risks tied to [the] virus" for those already with underlying health conditions; it was not implying that vaping itself caused those effects.